Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lucía Morales-Cacho"'
Autor:
Marina Salmón, Ruth Álvarez-Díaz, Coral Fustero-Torre, Oksana Brehey, Carmen G. Lechuga, Manuel Sanclemente, Fernando Fernández-García, Alejandra López-García, María Carmen Martín-Guijarro, Sandra Rodríguez-Perales, Emily Bousquet-Mur, Lucía Morales-Cacho, Francisca Mulero, Fátima Al-Shahrour, Lola Martínez, Orlando Domínguez, Eduardo Caleiras, Sagrario Ortega, Carmen Guerra, Monica Musteanu, Matthias Drosten, Mariano Barbacid
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 7 (2023)
KRASG12C inhibitors have revolutionized the clinical management of patients with KRASG12C-mutant lung adenocarcinoma. However, patient exposure to these inhibitors leads to the rapid onset of resistance. In this study, we have used genetically engine
Externí odkaz:
https://doaj.org/article/a51ce49b33904d3e80b5fe3757365959
Autor:
Verónica Ayllón, Marina Vogel-González, Federico González-Pozas, Joan Domingo-Reinés, Rosa Montes, Lucía Morales-Cacho, Verónica Ramos-Mejía
Publikováno v:
Stem Cell Research, Vol 19, Iss , Pp 1-5 (2017)
Pediatric Acute Megakaryoblastic Leukemia not associated to Down Syndrome (non-DS AMKL) is a rare disease with a dismal prognosis. Around 15% of patients carry the chromosomal translocation t(1;22) that originates the fusion oncogene RBM15-MKL1, whic
Externí odkaz:
https://doaj.org/article/22ac828119c44809b53f418fd5b400ba
Autor:
Lucía Morales-Cacho, Federico González-Pozas, Marina Vogel-González, Joan Domingo-Reinés, Verónica Ramos-Mejía, Verónica Ayllón, Rosa Montes
Publikováno v:
Stem Cell Research, Vol 19, Iss, Pp 1-5 (2017)
Pediatric Acute Megakaryoblastic Leukemia not associated to Down Syndrome (non-DS AMKL) is a rare disease with a dismal prognosis. Around 15% of patients carry the chromosomal translocation t(1;22) that originates the fusion oncogene RBM15-MKL1, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f659e02ac445c20de06b211fe94634db